135 related articles for article (PubMed ID: 36951043)
1. Hierarchical superparamagnetic metal-organic framework nanovectors as anti-inflammatory nanomedicines.
Zhao H; Sene S; Mielcarek AM; Miraux S; Menguy N; Ihiawakrim D; Ersen O; Péchoux C; Guillou N; Scola J; Grenèche JM; Nouar F; Mura S; Carn F; Gazeau F; Dumas E; Serre C; Steunou N
J Mater Chem B; 2023 Apr; 11(14):3195-3211. PubMed ID: 36951043
[TBL] [Abstract][Full Text] [Related]
2. A gold nanocluster/MIL-100(Fe) bimodal nanovector for the therapy of inflammatory disease through attenuation of Toll-like receptor signaling.
Zhao H; Becharef S; Dumas E; Carn F; Patriarche G; Mura S; Gazeau F; Serre C; Steunou N
Nanoscale; 2024 May; ():. PubMed ID: 38809107
[TBL] [Abstract][Full Text] [Related]
3. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
[TBL] [Abstract][Full Text] [Related]
4. Construction of Hyaluronic Acid-Covered Hierarchically Porous MIL-nanoMOF for Loading and Controlled Release of Doxorubicin.
Yao YR; Jin YJ; Jia X; Yang Y
Chemistry; 2021 Feb; 27(9):2987-2992. PubMed ID: 33169462
[TBL] [Abstract][Full Text] [Related]
5. PDA-coated CPT@MIL-53(Fe)-based theranostic nanoplatform for pH-responsive and MRI-guided chemotherapy.
Zhou C; Yang Q; Zhou X; Jia N
J Mater Chem B; 2022 Mar; 10(11):1821-1832. PubMed ID: 35201249
[TBL] [Abstract][Full Text] [Related]
6. Improving the genistein oral bioavailability
Botet-Carreras A; Tamames-Tabar C; Salles F; Rojas S; Imbuluzqueta E; Lana H; Blanco-Prieto MJ; Horcajada P
J Mater Chem B; 2021 Mar; 9(9):2233-2239. PubMed ID: 33596280
[TBL] [Abstract][Full Text] [Related]
7. Biocompatible porous metal-organic framework nanoparticles based on Fe or Zr for gentamicin vectorization.
Unamuno X; Imbuluzqueta E; Salles F; Horcajada P; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2018 Nov; 132():11-18. PubMed ID: 30179739
[TBL] [Abstract][Full Text] [Related]
8. Nanoscale Iron-Based Metal-Organic Frameworks: Incorporation of Functionalized Drugs and Degradation in Biological Media.
Christodoulou I; Lyu P; Soares CV; Patriarche G; Serre C; Maurin G; Gref R
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834775
[TBL] [Abstract][Full Text] [Related]
9. Advanced Characterization Methodology to Unravel the Biodegradability of Metal-Organic Framework Nanoparticles in Extremely Diluted Conditions.
Christodoulou I; Patriarche G; Serre C; Boissiére C; Gref R
ACS Appl Mater Interfaces; 2024 Mar; 16(11):14296-14307. PubMed ID: 38452344
[TBL] [Abstract][Full Text] [Related]
10. Magnetic bio-metal-organic framework nanocomposites decorated with folic acid conjugated chitosan as a promising biocompatible targeted theranostic system for cancer treatment.
Nejadshafiee V; Naeimi H; Goliaei B; Bigdeli B; Sadighi A; Dehghani S; Lotfabadi A; Hosseini M; Nezamtaheri MS; Amanlou M; Sharifzadeh M; Khoobi M
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():805-815. PubMed ID: 30889755
[TBL] [Abstract][Full Text] [Related]
11. Fabrication of Versatile Hollow Metal-Organic Framework Nanoplatforms for Folate-Targeted and Combined Cancer Imaging and Therapy.
Zeng X; Chen B; Song Y; Lin X; Zhou SF; Zhan G
ACS Appl Bio Mater; 2021 Aug; 4(8):6417-6429. PubMed ID: 35006919
[TBL] [Abstract][Full Text] [Related]
12. Controllable Synthesis of a Smart Multifunctional Nanoscale Metal-Organic Framework for Magnetic Resonance/Optical Imaging and Targeted Drug Delivery.
Gao X; Zhai M; Guan W; Liu J; Liu Z; Damirin A
ACS Appl Mater Interfaces; 2017 Feb; 9(4):3455-3462. PubMed ID: 28079361
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional Fe
Xu Y; Shan Y; Zhang Y; Yu B; Shen Y; Cong H
Nanotechnology; 2019 Oct; 30(42):425102. PubMed ID: 31261137
[TBL] [Abstract][Full Text] [Related]
14. Nanoscale metal-organic frameworks as key players in the context of drug delivery: evolution toward theranostic platforms.
Carrillo-Carrión C
Anal Bioanal Chem; 2020 Jan; 412(1):37-54. PubMed ID: 31734711
[TBL] [Abstract][Full Text] [Related]
15. Copper-olsalazine metal-organic frameworks as a nanocatalyst and epigenetic modulator for efficient inhibition of colorectal cancer growth and metastasis.
Li J; Zhang Z; Li J; Cun JE; Pan Q; Gao W; Luo K; He B; Gu Z; Pu Y
Acta Biomater; 2022 Oct; 152():495-506. PubMed ID: 36087871
[TBL] [Abstract][Full Text] [Related]
16. Iron-based porous metal-organic frameworks with crop nutritional function as carriers for controlled fungicide release.
Shan Y; Cao L; Muhammad B; Xu B; Zhao P; Cao C; Huang Q
J Colloid Interface Sci; 2020 Apr; 566():383-393. PubMed ID: 32018178
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
[TBL] [Abstract][Full Text] [Related]
18. Multimodal Imaging-Guided Strategy for Developing
Liang R; Li F; Chen X; Tan F; Lan T; Yang J; Liao J; Yang Y; Liu N
ACS Appl Mater Interfaces; 2023 Oct; 15(39):45713-45724. PubMed ID: 37738473
[TBL] [Abstract][Full Text] [Related]
19. MIL-100(Fe) Sub-Micrometric Capsules as a Dual Drug Delivery System.
Abuçafy MP; Frem RCG; Polinario G; Pavan FR; Zhao H; Mielcarek A; Boissiere C; Serre C; Chiavacci LA
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887018
[TBL] [Abstract][Full Text] [Related]
20. Coupling metal organic frameworks with molybdenum disulfide nanoflakes for targeted cancer theranostics.
Yang S; Li D; Chen L; Zhou X; Fu L; You Y; You Z; Kang L; Li M; He C
Biomater Sci; 2021 May; 9(9):3306-3318. PubMed ID: 33459315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
